Medicine & Life Sciences
Blood-Brain Barrier
100%
Zebrafish
94%
Receptor for Advanced Glycation End Products
70%
Ketamine
67%
Brain
67%
S-allylcysteine
59%
In Vitro Techniques
59%
Oxidopamine
53%
Embryonic Structures
52%
Amyloid
51%
Endothelial Cells
50%
Alzheimer Disease
46%
3,4-methylenedioxypyrovalerone
44%
Parkinson Disease
43%
Tight Junction Proteins
40%
Permeability
37%
3'-(1-butylphosphoryl)adenosine
37%
Dopamine
36%
Acetylcarnitine
34%
Quinolinic Acid
33%
Apoptosis
31%
Traumatic Brain Injury
31%
Toxicology
29%
cathinone phthalimide
29%
Reactive Oxygen Species
27%
Methamphetamine
27%
Microvessels
26%
Phosphotransferases
25%
fluoro-jade C
24%
Nicotine
23%
Gene Expression
23%
Oxidative Stress
23%
Poisons
23%
Prolactin
23%
Motor Neurons
22%
Hippocampus
21%
Transcriptional Activation
21%
Rodentia
21%
Nanoparticles
20%
Brain Concussion
20%
Occludin
20%
harman
19%
MicroRNAs
19%
Transcription Factors
19%
Antioxidants
19%
trimethyltin
19%
Amyloid Plaques
18%
amyloid beta-protein (25-35)
18%
tauroursodeoxycholic acid
18%
norharman
17%
Chemical Compounds
Ketamine
90%
Neurotoxicity
87%
Developmental
42%
Beta-Amyloid
41%
Dopamine
31%
Tyrosine
24%
Intrahippocampal
23%
Antioxidant Agent
23%
Cysteine
23%
Acetyl
23%
Biological Marker
22%
Neurotoxic
22%
Protein
21%
Safety
19%
Neurogenic
19%
Drug
17%
Cell Viability
17%
Trimethyltin
16%
Advanced Glycation End-Product
16%
Cytoprotective
16%
MicroRNA
14%
Neurotoxin
14%
Peptide
13%
Congo Red
13%
Nitric Oxide
12%
Clearance
12%
Cytochrome P450
12%
Toxic
11%
Ethidium Homodimer
10%
Cytochrome
10%
Lactate
9%
Anaesthetic
9%
Marker
8%
Graphene
8%
Cell Death
7%
Flow
7%
Molecule
7%
Permeability
6%
Environment
6%
Antagonist
6%
Modification
6%
Dose
6%
Qualitative Analysis
6%
Teratogenic
6%
Fragmentation
5%
Disorder
5%
Time
5%
Homovanillic Acid
5%